In a bid to expand its research operations to the South of India, Metropolis Healthcare acquired HiTech Diagnostic Centre, a diagnostic laboratory chain based in the…
With the COVID-19 pandemic conditions improving in India according to some local reports, the demand for antiviral drugs Remdesivir and Favipiravir, used to treat moderate…
India’s Bharat Biotech developed the first emergency authorized indigenously developed COVID-19 vaccine, which some critics have called “rushed” by the national regulatory body. TrialSite just wrote about…
By Mary Beth Pfeiffer She is a gynecologist. He is a surgeon. They are married and both 77 years old. In mid-November, they were diagnosed…
A number of scientists and patient advocacy groups share concern about the expedited approvals of two COVID-19 vaccine trials in India. Although the nation’s Prime Minister…
The Drugs Controller General of India (DCGI) issued emergency authorization for two vaccines, including ‘COVISHIELD’, produced by the Serum Institute of India (SII), which is…
A government-appointed panel of experts has apparently approved AstraZeneca’s COVID-19 vaccine –AZD1222, known as COVISHIELD in the world’s second most populated nation. And this panel…
As we reported on November 30, a clinical trial subject in India has sued the studied vaccine’s trial contractor and manufacturer. Now, in a new…
The European nation of Belgium is tightening up its relationships with life sciences industry players in Hyderabad in the State of Telangana, a leading Indian…
The world’s largest vaccine producer as measured by volume, Pune-based Serum Institute of India (SII), has found itself in a potential lawsuit in India due…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
